AAOS 2016: Topical injection and infusion for pain management in lumbar spine surgery .
Topical Injection and Infusion for Pain Management of Lumbar Spine Surgery
140 patients undergoing spinal fusion were randomized to receive a topical injection and infusion intraoperatively (bupivacaine, tromethamine, morphine, adrenalin) or to a control group that did not receive an intervention. The purpose of this study was to analyze the efficacy of this treatment in managing pain at up to 3 days postoperatively. The results of this study demonstrated that a significantly greater number of patients receiving the intervention displayed pain relief during the initial 24 postoperative hours when compared to the control group. The intervention group additionally had significantly fewer patients requiring patient controlled analgesia during the 3-day follow-up.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
